Excretion profile of 4-methylthioamphetamine in dogs

Pharmacy and Pharmacology Communications

Volumn 5, Issue 11, 1999, Pages 653-655

  Kavanagh, P V ^a   Corrigan, D ^a   Maguire, R T ^a   Meegan, M J ^a   Keating, J J ^a   Clancy, J ^a   Burdett, J ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b Trinity Court   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; TRIFLUOROACETAMIDE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DOG; DRUG ABUSE; DRUG EXCRETION; DRUG HALF LIFE; DRUG URINE LEVEL; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; GAS CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; ORAL DRUG ADMINISTRATION;

EID: 0033432676     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080899128734316     Document Type: Article

References (4)

1. de Boer, D., Egberts, T., Maes, R. A. (1999) Paramethylthioamphetamine, a new amphetamine designer drug of abuse. Pharm. World Sci. 21: 47-48
2. European Monitoring Centre for Drugs & Drug Addiction (1999) Report on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs
3. Holland, G. F., Buck, C. J., Weissman, A. (1963) Anorexigenic agents: aromatic substituted 1-phenyl-2-propylamines. J. Med. Chem. 6: 519-523
4. Poortman, A. J., Lock, E. (1999) Analytical profile of 4-methylthioamphetamine (4-MTA), a new street drug. Forensic Sci. Int. 100: 221-233